IBRX Competitors & Alternatives
Compare Immunitybio Inc with similar stocks in the same industry
Biotechnology
IBRX
Main Stock$6.10
Tradestie Score
40
Market Cap
$2.34B
Revenue Growth
0.5%
Analyst Upside
+133.6%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$23.86
|
$8.53B | 14.7 | 58 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$242.69
|
$8.30B | 72.6 | 24 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$56.34
|
$6.68B | - | 65 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$109.82
|
$6.64B | - | 31 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$90.90
|
$6.38B | - | 64 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$18.80
|
$6.03B | - | 42 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$42.90
|
$6.02B | - | 49 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$144.78
|
$5.92B | - | 55 | Compare |
More IBRX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
215 stocks in this industry